In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

CytomX Therapeutics, Inc.. Trade Record

NASDAQ:CTMX CytomX Therapeutics, Inc. stock gains 16.47% Exit Feb 5, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart CTMX Jan 3, 2018, priceSeries
About CytomX Therapeutics, Inc.

Preclinical biotech developing tumor-activated cancer immunotherapies.

Trade Information
Trade Type
LONG
ReliabilityScore™
93.55
Entry Date
Jan 3, 2018
Entry Price
22.39
Sell Date
Feb 5, 2018
Sell Price
26.08
Net Gain
16.47%
Hold Time
22 Trading Days